Did the UK Markets’ rise after the US House passed the Covid-19 stimulus package? UK Market Updates

March 02, 2021 04:29 PM AEDT | By Team Kalkine Media

Google News:

Recent News

UnitedHealth Group received multiple bids for Latin American operation...

Chevron CEO urged additional safety measures weeks before deadly Angol...

Citi lifts S&P 500 target

FTSE 100 today: Index flat ahead of U.S.-China talks in London; WPP CE...

UK Market News: The London markets traded in the green zone due to positive investor confidence regarding the US stimulus package and vaccine-led economic recovery. FTSE 100 traded higher by around 1.39%, primarily driven by homebuilders and mining stocks. The UK Manufacturing Purchasing Managers’ index was said to be 55.1 during February 2021 as compared to 54.1 during January 2021.

FTSE 100 listed Persimmon and Taylor Wimpey surged by around 4.98% and nearly 4.85%, respectively, driven by a media report that Rishi Sunak would announce a mortgage guarantee scheme along with the budget announcement on 03 March 2021.

Covid-19 vaccine provider AstraZeneca went up by approximately 0.72% after media reports that the Company had sold its stake in Moderna for more than USD 1.0 billion.

Gaming firm, Entain had raised the offer for Sweden-based Enlabs to approximately USD 438.50 million. Moreover, the shares rose by about 1.31%.

Distribution Group Bunzl shares jumped by around 0.31% after demonstrating a significant rise in FY20 profit and robust dividend growth.

Media Company Reach reported a 12.8% decline in the annual profit. Subsequently, the shares dropped by approximately 6.71%.

*At the time of writing

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.